Escalade, Inc. (ESCA)

NASDAQConsumer DiscretionaryLeisureSnapshot 2026-10-23

$18.54-1.85%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Escalade, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	63.81M
EPS	—	0.25
Annual ending 2026-12-31
Revenue	—	245.78M
EPS	—	1.585
Annual ending 2027-12-31
Revenue	—	253.2M
EPS	—	1.21

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Quarterly dividend per share at least $0.15	Escalade pays a steady quarterly dividend of $0.1525 per share.	Intact	quarterly dividend falls below $0.15 per share	Dividend per share: $0.15 per share FY2026-Q2; GAAP. Published target: >= $0.15 per share quarterly. The stored target says 2026-Q4; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Jul 30, 20260.1525 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 493ab822-7a37-47c5-aa2c-c8889e60f991. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS at least $1.08 for FY26	Escalade pays a steady quarterly dividend of $0.1525 per share.	Intact	EPS falls below $1.08 in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue decline limited to no worse than -6% YoY	A primary condition in Escalade, Inc.'s published investment case. The stated target is >= -6% YoY revenue growth.	Intact	revenue decline exceeds -6% YoY in FY26	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenue: comparable history unavailable.

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-10-14	Unavailable	Unavailable	1 / 1
2026-10-15	Unavailable	Unavailable	1 / 1
2026-10-16	Unavailable	Unavailable	1 / 1
2026-10-17	Unavailable	Unavailable	1 / 1
2026-10-18	Unavailable	Unavailable	1 / 1
2026-10-19	Unavailable	Unavailable	1 / 1
2026-10-20	Unavailable	Unavailable	1 / 1
2026-10-21	Unavailable	Unavailable	1 / 1
2026-10-22	Unavailable	Unavailable	1 / 1
2026-10-23	Unavailable	Unavailable	1 / 1
2026-10-24	Unavailable	Unavailable	1 / 1

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	1	0
2026-06-01	1	0
2026-07-01	1	0
2026-08-01	1	0
2026-09-01	1	0
2026-10-01	1	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 1 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Quarterly dividend per share at least $0.15Dividend per share: $0.15 per share
EPS at least $1.08 for FY26Direct metric needs a verified mapping
Revenue decline limited to no worse than -6% YoYDirect metric needs a verified mapping

Next proof point

Oct 29, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-19.3%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Escalade, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a smaller-cap company with strong recent performance and robust earnings quality, but elevated risk makes the thesis less steady than a typical durable compounder. The long-term thesis is intact, and the latest signal has improved to favorable.

What's priced into Escalade, Inc.

ESCA is described as cheap versus peers, with a justified priced-in tag and low valuation fragility. The evidence points to a negative expectations gap, so current expectations appear restrained rather than demanding; the model has high confidence in its valuation comparison.

What the fundamentals likely do

Near-term results show improving sales, with year-over-year growth rising from 0.6% in the first quarter to 6.2% in the second, alongside higher gross margins. Management is delivering on sales growth and capital allocation priorities, while margin progress remains worth watching; an upcoming guidance cut would be a meaningful negative, and recent earnings surprises have been erratic.

What Escalade, Inc. hinges on

The multi-year view depends on continued sales growth, sustained margin improvement, and disciplined capital allocation after recent acquisition activity. Near term, guidance is a key check, while earnings and guidance from sector bellwethers could either reinforce or weaken the broader sector backdrop.

Bottom line

As of 2026-10-24, the long-term thesis remains intact, supported by recent financial strength and peer-relative cheapness, but elevated risk and guidance uncertainty temper the picture. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.